lung adenocarcinoma phenotype

Aliases

LUAD

Related entities (5)

Mentioned in (78)

Papers in which this entity is mentioned.

• Meta-analysis reveals differences in somatic alterations by genetic ancestry across common cancers. (2025)
• DrBioRight 2.0: an LLM-powered bioinformatics chatbot for large-scale cancer functional proteomics analysis. (2025)
• Tumour-wide RNA splicing aberrations generate actionable public neoantigens. (2025)
• Functional analysis of cancer-associated germline risk variants. (2025)
• Three-dimensional genome landscape of primary human cancers. (2025)
• Tracing the evolution of single-cell 3D genomes in Kras-driven cancers. (2025)
• Transient loss of Polycomb components induces an epigenetic cancer fate. (2024)
• Insights for precision oncology from the integration of genomic and clinical data of 13,880 tumors from the 100,000 Genomes Cancer Programme. (2024)
• Analysis of 10,478 cancer genomes identifies candidate driver genes and opportunities for precision oncology. (2024)
• The Application of Long-Read Sequencing to Cancer. (2024)
• Combination of genomic instability score and TP53 status for prognosis prediction in lung adenocarcinoma. (2023)
• Comprehensive repertoire of the chromosomal alteration and mutational signatures across 16 cancer types from 10,983 cancer patients (2023)
• RNA splicing dysregulation and the hallmarks of cancer. (2023)
• Mapping clustered mutations in cancer reveals APOBEC3 mutagenesis of ecDNA. (2022)
• Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression. (2022)
• Spatially resolved whole transcriptome profiling in human and mouse tissue using Digital Spatial Profiling. (2022)
• Detecting cell-of-origin and cancer-specific methylation features of cell-free DNA from Nanopore sequencing. (2022)
• Inferring gene expression from cell-free DNA fragmentation profiles. (2022)
• Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA. (2021)
• Autosomal sex-associated co-methylated regions predict biological sex from DNA methylation. (2021)
• Evaluating the transcriptional fidelity of cancer models. (2021)
• Detection and characterization of lung cancer using cell-free DNA fragmentomes. (2021)
• Choline Kinase: An Unexpected Journey for a Precision Medicine Strategy in Human Diseases. (2021)
• Potential Role of S-Palmitoylation in Cancer Stem Cells of Lung Adenocarcinoma. (2021)
• Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes. (2021)
• DNA mismatch repair promotes APOBEC3-mediated diffuse hypermutation in human cancers. (2020)
• Immuno-genomic landscape of osteosarcoma. (2020)
• Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring. (2020)
• Distinct Classes of Complex Structural Variation Uncovered across Thousands of Cancer Genome Graphs. (2020)
• The repertoire of mutational signatures in human cancer. (2020)
• Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project. (2020)
• CHASMplus Reveals the Scope of Somatic Missense Mutations Driving Human Cancers. (2019)
• Determining cell type abundance and expression from bulk tissues with digital cytometry. (2019)
• Serial liquid biopsies for detection of treatment failure and profiling of resistance mechanisms in -rearranged lung cancer. (2019)
• Assessment of tumor mutation burden calculation from gene panel sequencing data. (2019)
• Driver Fusions and Their Implications in the Development and Treatment of Human Cancers. (2018)
• Quantification of subclonal selection in cancer from bulk sequencing data. (2018)
• Comprehensive Characterization of Cancer Driver Genes and Mutations. (2018)
• Genome doubling shapes the evolution and prognosis of advanced cancers. (2018)
• The Immune Landscape of Cancer. (2018)
• Tumor fraction in cell-free DNA as a biomarker in prostate cancer. (2018)
• Sensitivity to sequencing depth in single-cell cancer genomics. (2018)
• SvABA: genome-wide detection of structural variants and indels by local assembly. (2018)
• Patterns and mechanisms of structural variations in human cancer. (2018)
• Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. (2017)
• OncoKB: A Precision Oncology Knowledge Base. (2017)
• SVclone: inferring structural variant cancer cell fraction (2017)
• Integrated analysis of gene expression and copy number identified potential cancer driver genes with amplification-dependent overexpression in 1,454 solid tumors. (2017)
• Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution. (2017)
• Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. (2017)
• Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma. (2017)
• Comprehensive Analysis of Hypermutation in Human Cancer. (2017)
• DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution. (2016)
• Global analysis of somatic structural genomic alterations and their impact on gene expression in diverse human cancers. (2016)
• FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing. (2016)
• Comprehensive analyses of tumor immunity: implications for cancer immunotherapy. (2016)
• Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. (2016)
• Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets. (2015)
• Recurrent somatic mutations in regulatory regions of human cancer genomes. (2015)
• Systematic pan-cancer analysis of tumour purity. (2015)
• The landscape of long noncoding RNAs in the human transcriptome. (2015)
• Reconstructing A/B compartments as revealed by Hi-C using long-range correlations in epigenetic data. (2015)
• Comprehensive genomic profiles of small cell lung cancer. (2015)
• Unraveling the clonal hierarchy of somatic genomic aberrations. (2014)
• RADIA: RNA and DNA integrated analysis for somatic mutation detection. (2014)
• Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine. (2014)
• Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3'-UTR landscape across seven tumour types. (2014)
• An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. (2014)
• Inferring tumour purity and stromal and immune cell admixture from expression data. (2013)
• Signatures of mutational processes in human cancer. (2013)
• A rare population of CD24(+)ITGB4(+)Notch(hi) cells drives tumor propagation in NSCLC and requires Notch3 for self-renewal. (2013)
• Mutational heterogeneity in cancer and the search for new cancer-associated genes. (2013)
• Thalidomide-a notorious sedative to a wonder anticancer drug. (2013)
• An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. (2013)
• Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcoma. (2012)
• GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. (2011)
• Network of Cancer Genes: a web resource to analyze duplicability, orthology and network properties of cancer genes. (2010)
• Chromatin immunoprecipitation (ChIP) coupled to detection by quantitative real-time PCR to study transcription factor binding to DNA in Caenorhabditis elegans. (2008)

Merged raw entities (2)

All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.